跳到主要內容
big screen image small screen image
Font Size
A
A
A
轉寄 轉寄
(Exclusive License) Technology Transfer Enterprise Selection Announcement – Indoline derivatives for treatment  and/or prevention of tumor or cell proliferatinve and fibrosid diseases
Date of Announcement
2024-01-24

1TechnologyIndoline derivatives for treatment  and/or prevention of tumor or cell proliferatinve and fibrosid diseases

 

2ProviderProf. Chia-Ron Yang  School of Pharmacy, College of Medicine, NTU

 

3Enterprise Eligibility

(1). Industry Category: Biotechnology and medicine

(2). Required Technical Know-howNew drug development

(3). Required Machinery and EquipmentNone

(4). Required Research or Technical StaffNew drug  development

(5). Other RequirementsNone

 

4.How to apply? Please go to the Center of Industry-Academia Collaboration of the Office of Research and Development to inquire about relevant information.

 

5.Announcement period:From the announcement date to 2023/2/7, late applications will not be accepted. Those who send materials by mail shall use the postmark as evidence.

 

 

Intellectual Property & Licensing Manager: Lute Pan

TEL: +886-2-33669951

Email: lutepan@ntu.edu.tw

File download:
TechnologyTransferEnterpriseSelection-Indolinederivativesfor?treatment?and(or)prevention?of?tumor?or?cell?proliferatinve?and?fibrosid?diseases
File size: 69kb